Skip to content
homeHOME About Yuhan History

History

prev

2010~ now

2010~ now

2010~ now

2010~ now

next

2010~ now

  • 2018

    • Yuhan Corporation is recognized as the most respected company in Korea by the Korean Management Association
    • All Star 15 (first in Pharmaceuticals) 15 consecutive years
    • Yuhan Corporation, 2017 Revenue 1.4622 trillion won (#1 in the industry)
  • 2017

    • Received Korean Government’s ($200 million USD) Export Tower Award
    • Received 2017 The 41st National Productivity Award from Korean President
    • New Il-Han Award (Prof. Kim. H. S. Yonsei Univ)
  • 2016

    • The ninety(90) years of company establishment
    • All Star 13 (first in Pharmaceuticals) 13 consecutive years
  • 2015

    • All Star 12 (first in Pharmaceuticals) 12 consecutive years
  • 2014

    • All Star 11 (first in Pharmaceuticals) 11 consecutive years
  • 2013

    • Yuhan Corporation is recognized as the most respected company in Korea by the Korean Management Association
    • Received Korean government’s ($100 million USD) Export Tower Award
    • First in Korean pharmaceutical industry to receive 10th No-Accident certificate
  • 2012

    • Established strategic alliance with HanAll Biopharma Co., Ltd., of Seoul, Korea
    • Received Innovative Pharmaceutical Enterprise certification from the Korean Ministry of Health and Welfare
  • 2011

    • Cooperative development contract with Esoltek investment for degenerative arthritis medication
  • 2010

    • Revanex Out-Licensing to China
    • Ochang plant received KOSHA 18001/OHAS 18001 certification
    • Received 2010 Labor and Culture Award from Korean Prime Minister